Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer

Journal: Science Translational Medicine

Published: 2020-04-01

DOI: 10.1126/scitranslmed.aaz3577

Affiliations: 8

Authors: 20

Go to article
Institutions Share
The University of Texas MD Anderson Cancer Center, United States of America (USA) 1

Return